News Focus
News Focus
Followers 140
Posts 11663
Boards Moderated 0
Alias Born 03/15/2011

Re: DewDiligence post# 245590

Monday, 12/14/2015 5:01:25 PM

Monday, December 14, 2015 5:01:25 PM

Post# of 347009
DD, not so bad a geuss.

After all they are in the B-I network and they offer a brand new facility.

Then again, one would think that in the production of Biologics the B-I model becomes some less flexible given the need for FDA approval for each line and the need of a root molecule.

So shifting manufacturing around as in the 'bakery' approach where all know and are equipped to make bread, will be more difficult with biologics.

Maybe AVID I will do the bakery-grade productions and all biologics are made in Avid II as of now.

Peregrine Pharmaceuticals the Microsoft of Biotechnology! All In My Opinion. I am not advising anything, nor accusing anyone.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y